Recent RSLS News
- Form 8-K - Current report • Edgar (US Regulatory) • 10/17/2024 01:15:24 PM
- Form S-4 - Registration of securities, business combinations • Edgar (US Regulatory) • 10/01/2024 09:22:02 PM
- Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 09/26/2024 08:45:20 PM
- ReShape Lifesciences Announces 1-for-58 Reverse Stock Split • GlobeNewswire Inc. • 09/19/2024 12:31:00 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 08/28/2024 08:03:01 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 08/28/2024 08:01:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2024 08:45:10 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2024 08:30:30 PM
- ReShape Lifesciences® Reports Second Quarter Ended June 30, 2024 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 08/14/2024 08:05:00 PM
- ReShape Lifesciences® to Announce Financial Results for the Second Quarter Ended June 30, 2024, and Provide Corporate Update • GlobeNewswire Inc. • 08/13/2024 12:31:00 PM
- Vyome to go public and trade on the Nasdaq Capital Market under the ticker symbol “HIND” • GlobeNewswire Inc. • 07/09/2024 04:13:13 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 07/09/2024 01:22:48 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/09/2024 01:21:22 PM
- ReShape Lifesciences® Enters Into Merger Agreement With Vyome Therapeutics and Asset Purchase Agreement With Biorad Medisys • GlobeNewswire Inc. • 07/09/2024 12:31:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/20/2024 09:14:35 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/15/2024 08:50:53 PM
- ReShape Lifesciences® Reports First Quarter Ended March 31, 2024 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 05/15/2024 08:05:00 PM
- ReShape Lifesciences® to Announce Financial Results for the First Quarter Ended March 31, 2024, and Provide Corporate Update • GlobeNewswire Inc. • 05/14/2024 12:31:00 PM
- ReShape Lifesciences® Reports Year Ended December 31, 2023 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 04/01/2024 08:05:00 PM
- ReShape Lifesciences® Receives Notice of Allowance for Additional U.S. Patent Related to an Intragastric Balloon System • GlobeNewswire Inc. • 03/28/2024 12:31:00 PM
- ReShape Lifesciences® Provides Update on 2024 Cost Reduction Plan and Reorganization to Prioritize Commercialization of Lap-Band® 2.0 FLEX • GlobeNewswire Inc. • 03/04/2024 01:31:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/26/2024 09:19:43 PM
- ReShape Lifesciences® Announces First Surgeries Utilizing Next-Generation Lap-Band® 2.0 FLEX • GlobeNewswire Inc. • 02/22/2024 01:31:00 PM
- ReShape Lifesciences® Conducts Bariatric Fellows Training for its Lap-Band® System, Highlighting the Next-Generation Lap-Band® 2.0 FLEX • GlobeNewswire Inc. • 01/24/2024 01:31:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/18/2024 09:38:03 PM
SANUWAVE Announces Record Quarterly Revenues: Q3 FY2024 Financial Results • SNWV • Nov 8, 2024 7:07 AM
DBG Pays Off $1.3 Million in Convertible Notes, which Retires All of the Company's Convertible Notes • DBGI • Nov 7, 2024 2:16 PM
SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service • SMX • Nov 7, 2024 8:48 AM
Rainmaker Worldwide Inc. (OTC: RAKR) Announces Successful Implementation of 1.6 Million Liter Per Day Wastewater Treatment Project in Iraq • RAKR • Nov 7, 2024 8:30 AM
SBC Medical Group Holdings and MEDIROM Healthcare Technologies Announce Business Alliance • SBC • Nov 7, 2024 7:00 AM
VAYK Confirms Insider Buying at Open Market • VAYK • Nov 5, 2024 10:40 AM